Clincosm LogoSign in Get a demo

Melanoma

Showing NaN - NaN of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Part 1, MELANOMA, SCCHN Trial in Worldwide (PF-06801591)

Completed
Has Results
  • Part 1
  • +8 more
  • Los Angeles, California
  • +66 more
Oct 29, 2021

Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Elly Mobile Phone Application)

Recruiting
  • Cancer
  • +22 more
  • Elly Mobile Phone Application
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 7, 2021

Melanoma Trial in Canada, United States (POL-103A, POL-103A without API)

Terminated
  • Melanoma
  • POL-103A
  • POL-103A without API
  • Chandler, Arizona
  • +64 more
Dec 6, 2021

Cervical Cancer, Gastric Cancer, Stomach Cancer Trial in United States (INCAGN02390)

Completed
  • Cervical Cancer
  • +20 more
  • Los Angeles, California
  • +3 more
Nov 12, 2021

Melanoma Trial in United States (Ipilimumab, Nivolumab)

Completed
Has Results
  • Melanoma
  • Duarte, California
  • +35 more
Sep 8, 2021

Melanoma Trial in Worldwide (nivolumab, ipilimumab)

Completed
Has Results
  • Melanoma
  • nivolumab
  • ipilimumab
  • Tucson, Arizona
  • +123 more
Aug 24, 2021

Melanoma, Skin Cancer Trial in Worldwide (BMS-986205, Nivolumab, Placebo)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Los Angeles, California
  • +62 more
Jun 18, 2021

Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)

Active, not recruiting
  • Metastatic Cancer
  • +4 more
  • VE800
  • +2 more
  • Scottsdale, Arizona
  • +17 more
Jun 22, 2021

Melanoma Trial in Worldwide (LGX818, MEK162, LEE011)

Active, not recruiting
  • Melanoma
  • Los Angeles, California
  • +31 more
Jun 11, 2021

Melanoma Trial in United States (TAK-580, TAK-202, vedolizumab)

Terminated
Has Results
  • Melanoma
  • Tucson, Arizona
  • +13 more
Mar 3, 2021

Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Australia, United States (AMG 232, Trametinib, Dabrafenib)

Completed
  • Advanced Malignancy
  • +6 more
  • AMG 232
  • +2 more
  • Los Angeles, California
  • +6 more
Mar 24, 2021

Melanoma Trial in Worldwide (GSK 2132231A, Placebo)

Terminated
Has Results
  • Melanoma
  • GSK 2132231A
  • Placebo
  • Birmingham, Alabama
  • +256 more
Feb 5, 2021

Melanoma Trial in United States (ipilimumab, nivolumab)

Completed
Has Results
  • Melanoma
  • Los Angeles, California
  • +6 more
Feb 2, 2021

Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

Completed
Has Results
  • Melanoma
  • Scottsdale, Arizona
  • +120 more
Feb 8, 2021

Melanoma Trial in Canada, United States (rIL-21, Dacarbazine)

Completed
Has Results
  • Melanoma
  • Los Angeles, California
  • +18 more
Dec 8, 2020

Melanoma Trial in Worldwide (Immunotherapeutic GSK2132231A)

Completed
Has Results
  • Melanoma
  • Immunotherapeutic GSK2132231A
  • Los Angeles, California
  • +62 more
Dec 7, 2020

B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

Completed
  • B-cell Malignancies
  • +7 more
  • Nivolumab (Phase 1)
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 26, 2020

Melanoma Trial in Worldwide (pembrolizumab + epacadostat, pembrolizumab + )

Completed
Has Results
  • Melanoma
  • pembrolizumab + epacadostat
  • pembrolizumab + placebo
  • Birmingham, Alabama
  • +128 more
Aug 14, 2020

Melanoma Trial in Los Angeles (dendritic cell-MART-1 peptide vaccine, leukapheresis)

Completed
  • Melanoma
  • dendritic cell-MART-1 peptide vaccine
  • leukapheresis
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Cutaneous Melanoma, Melanoma Trial in Los Angeles (procedure, device, drug)

Terminated
  • Cutaneous Melanoma
  • Melanoma
  • Sentinel Lymph Node Biopsy
  • +2 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Mar 26, 2020

Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

Terminated
Has Results
  • Melanoma
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Feb 18, 2020

Melanoma Trial in United States (glembatumumab vedotin, glembatumumab vedotin and varlilumab, glembatumumab vedotin and PD-1

Terminated
Has Results
  • Melanoma
  • glembatumumab vedotin
  • +3 more
  • Los Angeles, California
  • +13 more
Sep 5, 2019

Melanoma Trial in Worldwide (Ipilimumab)

Completed
Has Results
  • Melanoma
  • Ipilimumab
  • Los Angeles, California
  • +87 more
Jul 29, 2019

Melanoma Trial in Worldwide (Vemurafenib, Placebo)

Completed
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +206 more
Jul 11, 2019